322 research outputs found

    Series Expansion based Efficient Architectures for Double Precision Floating Point Division

    Get PDF
    postprin

    Configurable Architectures For Multi-mode Floating Point Adders

    Get PDF
    published_or_final_versio

    Unified Architecture for Double/Two-Parallel Single Precision Floating Point Adder

    Get PDF
    postprin

    A pro-drug of the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) prevents differentiated SH-SY5Y cells from toxicity induced by 6-hydroxydopamine

    Get PDF
    Regular consumption of green tea benefits people in prevention from cardiovascular disorders, obesity as well as neurodegenerative diseases. (-)-Epigallocatechin-3-gallate (EGCG) is regarded as the most biologically active catechin in green tea. However, the stability and bioavailability of EGCG are restricted. The purpose of the present study was to investigate whether a pro-drug, a fully acetylated EGCG (pEGCG), could be more effective in neuroprotection in Parkinsonism mimic cellular model. Retinoic acid (RA)-differentiated neuroblastoma SH-SY5Y cells were pre-treated with different concentrations of EGCG and pEGCG for 30 min and followed by incubation of 25 μM 6-hydroxydopamine (6-OHDA) for 24 h. We found that a broad dosage range of pEGCG (from 0.1 to 10 μM) could significantly reduce lactate dehydrogenase release. Likewise, 10 μM of pEGCG was effective in reducing caspase-3 activity, while EGCG at all concentrations tested in the model failed to attenuate caspase-3 activity induced by 6-OHDA. Furthermore, Western-blot analysis showed that Akt could be one of the specific signaling pathways stimulated by pEGCG in neuroprotection. It was demonstrated that 25 μM of 6-OHDA significantly suppressed the phosphorylation level of Akt. Only pEGCG at 10 μM markedly increased its phosphorylation level compared to 6-OHDA alone. Taken together, as pEGCG has higher stability and bioavailbility for further investigation, it could be a potential neuroprotective agent and our current findings may offer certain clues for optimizing its application in future. © 2009 Elsevier Ireland Ltd. All rights reserved.postprin

    The inner centromere is a biomolecular condensate scaffolded by the chromosomal passenger complex.

    Get PDF
    The inner centromere is a region on every mitotic chromosome that enables specific biochemical reactions that underlie properties, such as the maintenance of cohesion, the regulation of kinetochores and the assembly of specialized chromatin, that can resist microtubule pulling forces. The chromosomal passenger complex (CPC) is abundantly localized to the inner centromeres and it is unclear whether it is involved in non-kinase activities that contribute to the generation of these unique chromatin properties. We find that the borealin subunit of the CPC drives phase separation of the CPC in vitro at concentrations that are below those found on the inner centromere. We also provide strong evidence that the CPC exists in a phase-separated state at the inner centromere. CPC phase separation is required for its inner-centromere localization and function during mitosis. We suggest that the CPC combines phase separation, kinase and histone code-reading activities to enable the formation of a chromatin body with unique biochemical activities at the inner centromere

    Studying kinetochore kinases

    Get PDF
    Mitotic kinetochores are signaling network hubs that regulate chromosome movements, attachment error-correction, and the spindle assembly checkpoint. Key switches in these networks are kinases and phosphatases that enable rapid responses to changing conditions. Describing the mechanisms and dynamics of their localized activation and deactivation is therefore instrumental for understanding the spatiotemporal control of chromosome segregation

    Neurodegeneration: the processes

    Get PDF
    Sumposium on Movement Disorders: Joint Symposium with the Hong Kong Movement Disorder Society and Hong Kong Baptist University (supported by Croucher Foundation)While neuronal apoptosis has long been considered to be the major mode of neurodegeneration in chronic neurological disorders in Parkinson’s disease, increasing lines of findings have demonstrated that neurodegeneration are mingle of autophagy, synaptic retraction, and axonal transport. Different survival and pro-apoptotic signalling pathways become biological targets for intervention. Apart from investigating the degenerative signalling in neurons, the responses of glial cells are important to determine the fate of dopaminergic neurons. Therefore, pharmacological interventions of neurodegenerative processes in Parkinson’s disease can be on both glial cells and neurons. I will at first briefly introduce different modes …published_or_final_versio
    corecore